Where does Dirk Landgraf work?

Dirk Landgraf is Principal at SV Health Investors.

What does Dirk Landgraf invest in?

Dirk Landgraf invests in Biotech.

What check size does Dirk Landgraf write?

Dirk Landgraf typically writes checks of $1M – $10M.

Dirk Landgraf

Investor

Principal at SV Health Investors

Boston, Massachusetts

Writes $1M – $10M checks · typically $5M

About

Dirk Landgraf joined SV Health Investors in 2020 and is a Principal on the Dementia Discovery Fund (DDF) team, where he helps form and fund companies developing new medicines for dementia and supports DDF portfolio companies with due diligence and strategic, business development, and operational needs. Before SV, he was an Associate Director in the External Innovation group at Biogen in Cambridge, MA, evaluating business development opportunities across neurological therapeutic areas, and earlier was a Postdoctoral Fellow in Susan Lindquist's lab at the Whitehead Institute at MIT. He holds a PhD from Harvard University's Department of Systems Biology at Harvard Medical School and BSc and MSc degrees in Biochemistry from the Technical University of Munich.

Invests in

Biotech

Experience

SV Health InvestorsPrincipalcurrent2020 — present
Dementia Discovery Fund (DDF)Principalcurrent2023 — presentBoston, Massachusetts, United States
Dementia Discovery Fund (DDF)Vice President2021 — 2023Boston, Massachusetts, United States
Dementia Discovery Fund (DDF)Senior Associate2020 — 2021Boston, Massachusetts, United States
Montara Therapeutics, Inc.Member Board of Directorscurrent2024 — presentSan Francisco Bay Area
Harness TherapeuticsBoard Observercurrent2023 — presentUnited Kingdom
Nitrase TherapeuticsBoard Observercurrent2025 — present
TranSINE TherapeuticsBoard Observer2020 — 2023United Kingdom
Tiaki TherapeuticsMember Board of Directors2021 — 2022Cambridge, Massachusetts, United States
BiogenAssociate Director, External Innovation and New Indications2019 — 2020
BiogenSenior Manager, External Innovation and New Indications2019
BiogenSenior Manager, External Portfolio Innovation Unit2019Greater Boston Area
BiogenManager, External Portfolio Innovation Unit2018 — 2019
BiogenManager, Business Development and External Innovation2016 — 2018
Whitehead Institute for Biomedical Research - MITPostdoctoral Fellow2013 — 2016Cambridge, Massachusetts, United States
Evelo BiosciencesIP/Biotech Part-time Consultant2015Cambridge, MA
Harvard Medical SchoolResearch Scientist / Postdoctoral Fellow2012Laboratory of Johan Paulsson
Harvard Medical SchoolPhD Student in the Harvard Systems Biology Program2006 — 2012Department of Systems Biology, Laboratory of Johan Paulsson
Harvard UniversityTeaching Fellow2008Cambridge, MA, USA
Dana-Farber Cancer InstituteVisiting Scientist at Dana-Farber Cancer Institute2005 — 2006Laboratory of Pam Silver

Education

Harvard UniversityDoctor of Philosophy (PhD), Systems Biology2006 — 2012
Technical University of MunichMaster of Science (MSc), Biochemistry2003 — 2005
Technical University of MunichBachelor of Science (BSc), Biochemistry2000 — 2003
Harvard Business School OnlineCore: Credential of Readiness2015

Skills & more

Matlab2PythonMATLABMolecular Biology27Cell Biology22Microscopy20Biochemistry13Fluorescence Microscopy12Cell Culture8Genetics7Protein Expression6Molecular Cloning6

+12 more

Western BlottingGenomicsPCRProtein PurificationBiotechnologyMicrobiologyLife SciencesIntellectual PropertyNeuroscienceStatisticsData AnalysisEntrepreneurship

Languages English · German

From Dirk's professional profile.

Colleagues at SV Health Investors

A.J. Rossi

Partner at SV Health Investors

Aaron Sandoski

MCF Partner at SV Health Investors

Alex Badamchi-Zadeh

Vice President at SV Health Investors

Andrew Cappetta

Senior Associate at SV Health Investors

Brent Faduski

CFO, CCO and Partner at SV Health Investors

Charles Dunn

Principal at SV Health Investors

Christian Jung

Partner at SV Health Investors

Darren Black

Partner at SV Health Investors

Network4

Alex Badamchi-Zadeh

Vice President at SV Health Investors

Charles Dunn

Principal at SV Health Investors

Christian Jung

Partner at SV Health Investors

Darren Black

Partner at SV Health Investors

Investors connected to Dirk in public investor directories — a warm-intro map.

Frequently asked questions

Where does Dirk Landgraf work?: Dirk Landgraf is Principal at SV Health Investors.
What does Dirk Landgraf invest in?: Dirk Landgraf invests in Biotech.
What check size does Dirk Landgraf write?: Dirk Landgraf typically writes checks of $1M – $10M.

Same school

Also attended Harvard University1,457

Alfred LinPartner at Sequoia Capital Chris DixonFounder & Managing Partner of a16z crypto at Andreessen Horowitz Sarah TavelVenture Partner at Benchmark Danny RimerPartner at Index Ventures Laela SturdyManaging Partner at CapitalG Ryan IsonoDeal Partner at Felicis Ventures

+ 1,451 more

Also attended Technical University of Munich258

Daan BoekhoudtInvestment Analyst at Cottonwood Technology Fund Julian von EckartsbergManaging Director Europe at Burda Principal Investments Hannes Voucko-GlocknerInvestment Analyst at Burda Principal Investments Thomas MeierPartner, Head of Resilience in Energy & Resources Investments at Verve Ventures Niklas Born de AndrésInvestment & Product Intern at Kibo Ventures Itziar EstevezPartner - Growth at Iris Capital

+ 252 more

Also attended Harvard Business School Online142

MariaInvestor at Investinor Kelsey BeausoleilBusiness Development Network at Redpoint Ventures Oliver MarquesPartner, Capital Formation at March Capital Partners John DemeterInvestor at Khosla Ventures Jeff RoseAdvisor at AI Capital RobAdvisor at TFX Capital

+ 136 more

Shared employers

Also worked at Dementia Discovery Fund (DDF)3

Jonathan BehrPartner at SV Health Investors Miles GersonGeneral Partner at SV Health Investors Christian JungPartner at SV Health Investors

Also worked at Biogen27

Jigar RaythathaInvestor at Third Rock Ventures Richard RansohoffVenture Partner at Third Rock Ventures Isaiah Baril-DoreInvestor at Index Ventures Steve HoltzmanBio Advisor at Amplify Partners Roy LobbVenture Partner at Advent Life Sciences Sun AltbachSenior Scientific Advisor at BOLD Longevity

+ 21 more

Also worked at Whitehead Institute for Biomedical Research - MIT10

Satish JindalGeneral Partner at Advent Life Sciences Stella PaffenholzSenior Associate at Atlas Venture Betsy MuléPrincipal at F-Prime Capital Partners BeccaInvestor at Sanofi Ventures Jakob LovenPartner at Nextech Invest Michael LamprechtInvestment Manager at Tenmile

+ 4 more

Also worked at Harvard Medical School162

Logan HilleLife Sciences Analyst at CincyTech Ankit GuptaGeneral Partner at Y Combinator David MollerInvestor at Third Rock Ventures Julie YangInvestor at Third Rock Ventures Tracy WilliamsInvestor at Third Rock Ventures Samuel ArbesmanVenture Partner at Lux Capital

+ 156 more